Neuro-oncologistCenter for Neuro-Oncology, Dana-Farber Cancer Institute, Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA, United States
Disclosure information not submitted.
Advancing therapeutic clinical trial equity: drivers of enrollment for diverse patients with low- and high-grade glioma
Saturday, May 4, 20242:33 PM – 2:35 PM CT